Sign inJoin waitlistJoin the waitlist

Gregory Halligan

Site Director, St. Christopher's Hospital for Children · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY

Credentials: · · · ·

History

DREXEL UNIVERSITY
Present

St Christopher's Hospital for Children
1980–1981
Pediatrics
St Christopher's Hospital for Children
1977–1980
UNIV LIBRE DE BRUXELLES, BRUXELLES
1973–1977

Research

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders
Science · 1986 · 1,234 citations
Translocation 10;17 in clear cell sarcoma of the kidney. A first report
Case report · Cancer Genetics and Cytogenetics · 1989 · 47 citations
FOXO1-FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma
Case report · Modern Pathology · 2011 · 46 citations

JC
Jean-Pierre de Chadarevian
9 papers
CK
Christos Katsetos
4 papers
JL
Jinglan Liu
4 papers
EF
Eric Faerber
2 papers
Matthew Keisling
2 papers
Stephen Dunn
2 papers
AL
Agustin Legido
1 paper
AS
Ayman Samkari
1 paper
BS
Brian Samuels
1 paper
Bruce Pawel
1 paper
CB
Catherine Bodak-Gyovai
1 paper
Charles Vinocur
1 paper

Clinical trials

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2026–2031
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Site PI · Recruiting · Phase 2
Children's Oncology Group
2024–2033